ALNY
Alnylam Pharmaceuticals
Stock NASDAQ – Stock Market Prices, News & Analysis
Alnylam Pharmaceuticals Inc is a biopharmaceutical company focused on developing RNA interference-based therapies.
Alnylam Pharmaceuticals
ALNY
Alnylam Pharmaceuticals Inc is a biopharmaceutical company focused on developing RNA interference-based therapies.
Price history of Alnylam Pharmaceuticals
Price history of Alnylam Pharmaceuticals
Performance & Momentum
Strategic Analysis
Alnylam Pharmaceuticals • 2026
Alnylam Pharmaceuticals is a specialized player in innovative RNA interference-based therapies, leveraging a niche positioning in biotechnology to address rare and complex pathologies. Its model relies on advanced research and the selective commercialization of differentiated treatments, reinforcing its place in a highly dynamic innovation sector.
Strengths
- Pioneer and leader in RNA interference technology with a strong clinical portfolio
- Focus on rare diseases with high potential for added value and low competition
- Robust historical growth demonstrating the commercial viability of its therapies
Weaknesses
- High sensitivity to clinical results and health regulations
- Notable volatility related to the biotechnology sector and dependence on future innovations
Momentum
Despite a marked recent correction, the positive annual trend illustrates a renewed confidence among investors in the long-term growth potential. This momentum suggests a strategic opportunity for risk-tolerant profiles favoring breakthrough therapeutic values.
Similar stocks to Alnylam Pharmaceuticals
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
